Myeloma is a cancer that starts from immune cells in the bone marrow. Around 15 people are diagnosed with the disease each day. Survival is improving all the time – a third of people will now survive their disease for at least 10 years. But we know we need to do better, so our researchers are working hard to save more lives, now and in the future.
From studying the biology of myeloma cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive myeloma.
Thanks to research, we’ve helped change the outlook for people with myeloma.
Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.
We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.
Browse the latest news, analysis and opinion from Cancer Research UK.
Want to find more information about our research or myeloma?